Department of Chemistry , University at Buffalo, SUNY , Buffalo , New York 14260-3000 , United States.
Acc Chem Res. 2018 Apr 17;51(4):960-969. doi: 10.1021/acs.accounts.8b00059. Epub 2018 Mar 29.
The mystery associated with catalysis by what were once regarded as protein black boxes, diminished with the X-ray crystallographic determination of the three-dimensional structures of enzyme-substrate complexes. The report that several high-resolution X-ray crystal structures of orotidine 5'-monophosphate decarboxylase (OMPDC) failed to provide a consensus mechanism for enzyme-catalyzed decarboxylation of OMP to form uridine 5'-monophosphate, therefore, provoked a flurry of controversy. This controversy was fueled by the enormous 10-fold rate acceleration for this enzyme, which had " jolted many biochemists' assumptions about the catalytic potential of enzymes." Our studies on the mechanism of action of OMPDC provide strong evidence that catalysis by this enzyme is not fundamentally different from less proficient catalysts, while highlighting important architectural elements that enable a peak level of performance. Many enzymes undergo substrate-induced protein conformational changes that trap their substrates in solvent occluded protein cages, but the conformational change induced by ligand binding to OMPDC is incredibly complex, as required to enable the development of 22 kcal/mol of stabilizing binding interactions with the phosphodianion and ribosyl substrate fragments of OMP. The binding energy from these fragments is utilized to activate OMPDC for catalysis of decarboxylation at the orotate fragment of OMP, through the creation of a tight, catalytically active, protein cage from the floppy, open, unliganded form of OMPDC. Such utilization of binding energy for ligand-driven conformational changes provides a general mechanism to obtain specificity in transition state binding. The rate enhancement that results from the binding of carbon acid substrates to enzymes is partly due to a reduction in the carbon acid p K that is associated with ligand binding. The binding of UMP to OMPDC results in an unusually large >12 unit decrease in the p K = 29 for abstraction of the C-6 substrate hydrogen, due to stabilization of an enzyme-bound vinyl carbanion, which is also an intermediate of OMPDC-catalyzed decarboxylation. The protein-ligand interactions operate to stabilize the vinyl carbanion at the enzyme active site compared to aqueous solution, rather than to stabilize the transition state for the concerted electrophilic displacement of CO by H that avoids formation of this reaction intermediate. There is evidence that OMPDC induces strain into the bound substrate. The interaction between the amide side chain of Gln-215 from the phosphodianion gripper loop and the hydroxymethylene side chain of Ser-154 from the pyrimidine umbrella of ScOMPDC position the amide side chain to interact with the phosphodianion of OMP. There are no direct stabilizing interactions between dianion gripper protein side chains Gln-215, Tyr-217, and Arg-235 and the pyrimidine ring at the decarboxylation transition state. Rather these side chains function solely to hold OMPDC in the catalytically active closed conformation. The hydrophobic side chains that line the active site of OMPDC in the region of the departing CO product may function to stabilize the decarboxylation transition state by providing hydrophobic solvation of this product.
曾经被视为蛋白质“黑盒子”的酶的催化作用的奥秘,随着酶-底物复合物三维结构的 X 射线晶体学测定而逐渐减少。有报道称,几个高分辨率的乳清酸 5'-单磷酸脱羧酶(OMPDC)的 X 射线晶体结构未能为酶催化 OMP 脱羧形成尿嘧啶 5'-单磷酸提供共识机制,因此引发了激烈的争议。这种争议是由该酶巨大的 10 倍的速率加速引起的,这“震惊了许多生物化学家对酶催化潜力的假设”。我们对 OMPDC 作用机制的研究提供了强有力的证据,证明该酶的催化作用与效率较低的催化剂没有根本区别,同时突出了实现最高性能水平的重要结构元素。许多酶经历底物诱导的蛋白质构象变化,将其底物困在溶剂包埋的蛋白质笼中,但配体结合 OMPDC 诱导的构象变化非常复杂,需要与 OMP 的磷酸二阴离子和核糖基底物片段形成 22 千卡/摩尔的稳定结合相互作用。来自这些片段的结合能被用于激活 OMPDC,以催化 OMP 脱羧,形成紧密的、催化活性的蛋白质笼,从 OMPDC 的松散、开放、无配体形式中形成。这种利用结合能进行配体驱动的构象变化为在过渡态结合中获得特异性提供了一种通用机制。与酶结合的碳酸底物的速率增强部分归因于碳酸的 pK 的降低,这与配体结合有关。UMP 与 OMPDC 的结合导致 C-6 底物氢的抽象的 pK 值异常降低了>12 个单位,这是由于酶结合的乙烯基碳负离子的稳定,这也是 OMPDC 催化脱羧的中间体。蛋白质-配体相互作用的作用是将乙烯基碳负离子稳定在酶活性部位,而不是稳定协同亲电取代 CO 的过渡态,从而避免形成这种反应中间体。有证据表明 OMPDC 诱导结合底物产生应变。来自磷酸二阴离子夹子环的 Gln-215 的酰胺侧链与来自 ScOMPDC 的嘧啶伞的 Ser-154 的羟亚甲基侧链之间的相互作用将酰胺侧链定位为与 OMP 的磷酸二阴离子相互作用。在脱羧过渡态中,二阴离子夹子蛋白侧链 Gln-215、Tyr-217 和 Arg-235 与嘧啶环之间没有直接的稳定相互作用。相反,这些侧链仅用于将 OMPDC 保持在催化活性的封闭构象中。在 CO 产物离开的区域,OMPDC 的活性位点的疏水性侧链可能通过为产物提供疏水溶剂化来稳定脱羧过渡态。